Share this post on:

Product Name :
Fosravuconazole L-Lysine Ethanolate

Search keywords :
Fosravuconazole

drugId :
null

Target Vo:
Cytochrome P450 51

Target Vo Short Name :
CYP51

Moa_Name:
Cytochrome P450 51 inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2018

Origin Company_Name :
Eisai Co Ltd

Active Company_Name :
Sato Pharmaceutical Ltd

Active Indication_Name:
Onychomycosis

In Active Indication_Name:
Chagas Disease

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-CDK1/2/3 (Thr14) Antibody
Phospho-Glycogen synthase 1 (S641) Antibody
SRT Tag Antibody (YA884): SRT Tag Antibody (YA884) is an unconjugated, mouse-derived, anti-SRT Tag (YA884) monoclonal antibody. SRT Tag Antibody (YA884) can be used for: WB expriments in species-independent background without labeling.

Share this post on:

Author: Interleukin Related